Filtered by Tag: Pomerantz LLP

Pomerantz Ranked by The Legal 500 as a Tier 1 Plaintiffs’ Securities Litigation Firm

After a vetting process that involved in-depth analysis of the Firm’s recent and current litigation actions, discussions with dozens of clients, colleagues, and judges, and interviews with Pomerantz partners, The Legal 500 ranked Pomerantz as a Tier 1 firm in recognition of its achievements as one of the top plaintiffs’ securities litigation firms in the United States. In describing their experiences with Pomerantz, testimonials from anonymous referees included: “The qualities of diligence…

Read More

Pomerantz Appointed Lead Counsel in MoneyGram Securities Litigation

On June 2, 2021, U.S. District Judge Karen Gren Scholer of the Northern District of Texas – Dallas Division appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Mohsen Javaherneshan in Javaherneshan v. MoneyGram International, Inc., 21-cv-815 (N.D. Tex.), a securities action brought on behalf of a class of defrauded investors concerning allegations that MoneyGram International, Inc. failed to disclose risks…

Read More

Pomerantz Appointed Co-Lead Counsel in AstraZeneca Securities Litigation

On April 28, 2021, U.S. District Judge J. Paul Oetken of the Southern District of New York appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiff Nuggehalli Balmukund Nandkumar in In re AstraZeneca plc Sec. Litig., 21-cv-722 (S.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that AstraZeneca plc failed to disclose to investors that its clinical trials…

Read More

Pomerantz Appointed Lead Counsel in Fortress Biotech Securities Litigation

On April 19, 2021, U.S. District Judge Kiyo A. Matsumoto of the Eastern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiffs Yasser Abed and Evay Avbenake in Cushman v. Fortress Biotech, Inc., 20-cv-5767 (E.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Fortress Biotech, Inc. failed to disclose that IV Tramadol…

Read More

Pomerantz Appointed Co-Lead Counsel in GoodRx Holdings Securities Litigation

On April 8, 2021, U.S. District Judge David O. Carter of the Central District of California (Western Division) appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiffs Betty Kalmanson, Lawrence Kalmanson and Shawn Kalmanson in In re GoodRx Holdings, Inc. Securities Litigation, 2:20-cv-11444-DOC-PD (C.D.Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations that GoodRx Holdings…

Read More

Pomerantz Appointed Lead Counsel in Northern Dynasty Minerals Securities Litigation

On March 17, 2021, U.S. Magistrate Judge Roanne L. Mann of the Eastern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Lawrence Kelemen in In re Northern Dynasty Minerals Ltd. Sec. Litig., 20-cv-5917 (E.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Northern Dynasty Minerals, Inc. misled investors regarding the compliance…

Read More

Pomerantz Defeats Motion to Dismiss in Altria Securities Class Action

On March 12, 2021, in Klein v. Altria Group, Inc. et al (3:20-cv-00075-DJNVAED), U.S. District Judge David J. Novak in the Eastern District of Virginia denied Altria Group, Inc.’s (“Altria”) and JUUL Labs, Inc’s (“JUUL”) motions to dismiss the plaintiffs’ complaint. The complaint alleges Exchange Act violations against JUUL, Altria and certain officers of each arising from Altria’s investment in JUUL and the failure to disclose their marketing of highly addictive nicotine products to kids…

Read More

Pomerantz Appointed Co-Lead Counsel in Restaurant Brands Securities Litigation

On March 11, 2021, Chief U.S. District Judge K. Michael Moore of the Southern District of Florida appointed Pomerantz LLP as Co-Lead Counsel on behalf of Lead Plaintiff Paul J. Graney in Graney v. Restaurant Brands International, Inc., 21-cv-20508 (S.D. Fla.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Restaurant Brands International misled investors…

Read More

Pomerantz Defeats Recro Pharma Motion to Dismiss

On March 1, 2021, Pomerantz received a very favorable decision from Judge Michael M. Baylson in Alberici v. Recro Pharma, Inc. et al, 2:18-cv-02279, a case currently pending in the Eastern District of Pennsylvania, when U.S. District Judge Michael M. Baylson issued a decision denying Defendants’ motion to dismiss the Second Amended Complaint. The Court issued a decision denying defendants’ motion to dismiss the Second Amended Complaint, holding that pled sufficient facts to support the reasonable inference…

Read More

Pomerantz Appointed Co-Lead Counsel in JOYY Securities Litigation

On February 23, 2021, U.S. District Judge Stanley Blumenfeld, Jr. of the Central District of California appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiff Suresh Goyal in Hershewe v. JOYY Inc. et al., 20-cv-10611 (C.D. Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations that JOYY Inc. misled investors regarding the source of its streaming traffic and the amount of its streaming revenue.

Read More

Pomerantz Appointed Lead Counsel in K12 Securities Litigation

On February 17, 2021, U.S. District Judge Liam O’Grady of the Eastern District of Virginia appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff James Boykin in In re K12 Inc. Securities Litigation, 20-cv-1419 (E.D. Va.), a securities action brought on behalf of a class of defrauded investors concerning allegations that K12 Inc. misled investors regarding its ability to meet the increased technological, administrative and infrastructure demands on its online…

Read More

Pomerantz Appointed Co-Lead Counsel in Zosano Pharma Securities Litigation

On February 4, 2021, U.S. District Judge Edward M. Chen of the Northern District of California appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiffs Hosam Alqurashi in Zosano Pharma Corporation, 20-cv-7625 (N.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Zosano Pharma Corporation misled investors regarding the results from…

Read More

Pomerantz Appointed Co-Lead Counsel in Endo International Securities Litigation

On February 4, 2021, U.S. District Judge Michael M. Baylson of the Eastern District of Pennsylvania appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiffs Alexandre Pelletier, Nathan Joseph Dole, and Lane A. Wingard in Pelletier v. Endo International plc, 17-cv-5114 (E.D. Pa.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Endo International…

Read More

Pomerantz Appointed Lead Counsel in First American Financial Securities Litigation

On January 27, 2021, U.S District Judge Dale S. Fischer of the Central District of California appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff St. Lucie County Fire District Firefighters Pension Trust Fund in In re First American Financial Corp. Securities Litigation, 20-cv-9781 (C.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that First American Financial Corp. failed…

Read More

Pomerantz Appointed Co-Lead Counsel in Neovasc Securities Litigation

On January 26, 2021, U.S District Judge Philip M. Halpern of the Southern District of New York appointed Pomerantz LLP as Co-Lead Counsel on behalf of Lead Plaintiff Pratap Golla in In re Neovasc Inc. Securities Litigation, 20-cv-9313 (S.D.N.Y.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Neovasc Inc. failed to disclose that the Company had misrepresented the viability of getting approval for its Reducer medical…

Read More

Pomerantz Elevates Four Attorneys to Of Counsel

Pomerantz LLP is proud to announce the promotions of attorneys Jennifer Banner Sobers, Samuel J. Adams, Veronica V. Montenegro and Omar Jafri to Of Counsel. Jennifer Banner Sobers focuses her practice on securities litigation. She played an integral role on a securities class action that arose from a multi-billion-dollar kickback and bribery scheme involving Brazil’s largest oil company, Petróleo Brasileiro S.A. - Petrobras. The Firm, as sole Lead Counsel, achieved a historic $3 billion settlement on behalf of defrauded…

Read More

Pomerantz Appointed Co-Lead Counsel in Cheetah Mobile Securities Litigation

On January 12, 2021, U.S District Judge Michael W. Fitzgerald of the Central District of California appointed Pomerantz LLP as Co-Lead Counsel on behalf of Lead Plaintiffs Guan Wei Mao and Jun Yu in In re Cheetah Mobile, Inc. Sec. Litig., 20-cv-5696 (C.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Cheetah Mobile, Inc. failed to disclose that some of the Company’s apps were not…

Read More